Individual generic drug information

levamisole

Reference monograph

Part of registered formulation

LEVAMISOLE

Reference record: Levamisole
Source: BNF 80 (2020–2021)
Printed source pages: 662
Age groups indexed: 1

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for Levamisole only.

Indications And Dose

Roundworm infections ▶BY MOUTH ▶Adult: 120–150 mg for 1 dose l UNLICENSED USE Not licensed.

Source page 662

Contra Indications

Blood disorders

Source page 662

Cautions

Epilepsy. Sjögren’s syndrome

Source page 662

Safety

Extracted information for Levamisole only.

Interactions

→Appendix 1: levamisole

Source page 662

Side Effects

Arthralgia (long term use). blood disorder (long term use). diarrhoea. dizziness. headache. inﬂuenza like illness (long term use). insomnia (long term use). myalgia (long term use). nausea. rash (long term use). seizure (long term use). taste altered (long term use) . vasculitis (long term use). vomiting

Source page 662

Pregnancy

Embryotoxic in animal studies, avoid if possible.

Source page 662

Breast Feeding

No information available.

Source page 662

Hepatic Impairment

Dose adjustments Use with caution—dose adjustment may be necessary.

Source page 662

Dose and formulations

Extracted information for Levamisole only.

Medicinal Forms

There can be variation in the licensing of different medicines containing the same drug. Forms available from special-order manufacturers include: tablet Tablet CAUTIONARY AND ADVISORY LABELS 4 ▶Ergamisol (Imported (Belgium)) Levamisole (as Levamisole hydrochloride) 50 mg Ergamisol 50mg tablets | 20 tablet P s

Source page 662

Dose text by age group

Filter the extracted dose blocks for this individual drug.

Adults

First line only; read the complete Indications and dose section above.

120–150 mg for 1 dose

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 662

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.

Individual generic drug information

levamisole

Reference monograph

Part of registered formulation

LEVAMISOLE

Reference record: Levamisole
Source: BNF 80 (2020–2021)
Printed source pages: 662
Age groups indexed: 1

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for Levamisole only.

Indications And Dose

Roundworm infections ▶BY MOUTH ▶Adult: 120–150 mg for 1 dose l UNLICENSED USE Not licensed.

Source page 662

Contra Indications

Blood disorders

Source page 662

Cautions

Epilepsy. Sjögren’s syndrome

Source page 662

Safety

Extracted information for Levamisole only.

Interactions

→Appendix 1: levamisole

Source page 662

Side Effects

Source page 662

Pregnancy

Embryotoxic in animal studies, avoid if possible.

Source page 662

Breast Feeding

No information available.

Source page 662

Hepatic Impairment

Dose adjustments Use with caution—dose adjustment may be necessary.

Source page 662

Dose and formulations

Extracted information for Levamisole only.

Medicinal Forms

Source page 662

Dose text by age group

Filter the extracted dose blocks for this individual drug.

Adults

First line only; read the complete Indications and dose section above.

120–150 mg for 1 dose

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 662

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.